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Herpes simplex virus blocks host transcription
termination via the bimodal activities of ICP27
Xiuye Wang 1, Thomas Hennig2, Adam W. Whisnant 2, Florian Erhard 2, Bhupesh K. Prusty 2,
Caroline C. Friedel 3, Elmira Forouzmand4,5, William Hu1, Luke Erber 6, Yue Chen6,
Rozanne M. Sandri-Goldin 1*, Lars Dölken 2,7* & Yongsheng Shi1*
Infection by viruses, including herpes simplex virus-1 (HSV-1), and cellular stresses cause
widespread disruption of transcription termination (DoTT) of RNA polymerase II (RNAPII) in
host genes. However, the underlying mechanisms remain unclear. Here, we demonstrate that
the HSV-1 immediate early protein ICP27 induces DoTT by directly binding to the essential
mRNA 3’ processing factor CPSF. It thereby induces the assembly of a dead-end 3’
processing complex, blocking mRNA 3’ cleavage. Remarkably, ICP27 also acts as a sequence-
dependent activator of mRNA 3’ processing for viral and a subset of host transcripts.
Our results unravel a bimodal activity of ICP27 that plays a key role in HSV-1-induced host
shutoff and identify CPSF as an important factor that mediates regulation of transcription
termination. These ﬁndings have broad implications for understanding the regulation of
transcription termination by other viruses, cellular stress and cancer.
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RNA polymerase II (RNAPII) transcription termination isan essential step in eukaryotic gene expression, but itsmechanism remains elusive1–4. Two models have been
proposed, the allosteric model and the torpedo model. In both
models, poly(A) site (PAS) and the mRNA 3′ processing
machinery are essential5–10. Most mammalian PAS consists of an
A(A/U)UAAA hexamer, a U/GU-rich downstream element, and
various auxiliary sequences11. These RNA sequences recruit the
mRNA 3′ processing factors CPSF, CstF, and CFIm, CFIIm and
the poly(A) polymerase to assemble the mRNA 3′ processing
complex. Within this complex, mRNA 3′ processing takes place
in two steps, an endonucleolytic cleavage and the subsequent
addition of a poly(A) tail. Many but not all mRNA 3′ processing
factors are required for transcription termination12.
Recent studies have revealed that RNAPII transcription termi-
nation is regulated. Through nascent RNA sequencing, we ﬁrst
demonstrated that lytic herpes simplex virus-1 (HSV-1) infection
induces widespread disruption of transcription termination (DoTT)
in host genes13. The Steitz group subsequently reported that osmotic
stress induces transcription downstream of human genes (DoGs)14.
Further studies demonstrated that inﬂuenza virus infection and
other cellular stresses, such as heat shock, also cause widespread
DoTT and that the genes affected by virus- and stress-induced
DoTT are highly correlated15. Importantly, pervasive DoTT was
observed in renal cell carcinoma due to the loss of the histone
methyltransferase SETD2 (ref. 16). The mechanisms of virus- or
stress-induced DoTT/DoGs, however, remain poorly deﬁned.
HSV-1 is a DNA virus that causes a number of diseases ranging
from painful skin lesions to encephalitis17. Like other viruses,
HSV-1 hijacks host factors to facilitate productive infection while
efﬁciently shutting down host gene expression. Its tegument
protein VP16 recruits the host transcription machinery to express
immediate early genes, including ICP0, ICP4, ICP27, and
ICP47. ICP4, in turn, activates the transcription of early and late
genes. ICP27 regulates viral gene expression through several
mechanisms, including splicing18, 3′ processing19,20, and mRNA
export21,22. Earlier studies provided evidence that ICP27 inhibits
splicing18. As most viral genes are intronless, ICP27-mediated
splicing inhibition was proposed to speciﬁcally block host gene
expression. Recent transcriptomic analyses, however, revealed
that neither HSV-1 infection nor ICP27 overexpression globally
inhibits splicing, but rather modulates alternative splicing of a
subset of cellular genes13,19, suggesting that splicing regulation is
not a major mechanism for HSV-1-induced host shutoff.
Here we dissect the molecular mechanism of HSV-1-induced
DoTT. Our data show that ICP27 blocks transcription termina-
tion of host genes by inhibiting mRNA 3′ processing. Meanwhile
ICP27 can act as a sequence-dependent activator of mRNA 3′
processing for viral transcripts. These results reveal a critical role
for ICP27 in mediating host shut-off during HSV-1 infection.
Results
The role of immediate early proteins in HSV-1-mediated
DoTT. Our previous transcriptome analysis of HSV-1-infected
cells detected widespread DoTT in host genes13. To characterize
the timing of DoTT, we monitored transcriptional activities at
different time points post-infection by 4-thiouridine (4sU) pulse-
labeling and high-throughput sequencing (4sU-seq)13. Signiﬁcant
DoTT was observed as early as 2 h post-infection (h.p.i.) and
steadily increased thereafter (Fig. 1a). To identify the responsible
viral gene(s), we infected primary human ﬁbroblast cells with
mutant viruses lacking key viral regulators (immediate early genes
and vhs) and quantiﬁed DoTT by 4sU-seq. While knockout
mutants of ICP0 and ICP22 as well as the key viral host shut-off
protein vhs still induced DoTT, this was substantially reduced
upon infection with viruses deﬁcient for ICP4 (ΔICP4 or TsK, a
temperature-sensitive mutant of ICP4) or ICP27 (ΔICP27)
(Fig. 1b). Among these viral genes, deletion of ICP27 resulted in
the greatest decrease in DoTT (Fig. 1b). Previously, we observed
a strong linear correlation between DoTT and the variance in
cellular mRNA expression changes during infection15. This cor-
relation was essentially maintained for the mutant viruses
including Δvhs, ΔICP22, ΔICP0 as well as ΔICP4 and TsK
(Fig. 1c). DoTT induced by infection with the latter two mutant
viruses matched DoTT observed 3–4 h.p.i. with wild-type (WT)
HSV-1. In contrast, DoTT for ΔICP27 was substantially reduced
compared to the observed alterations in host gene expression
infected with the WT HSV-1 (Fig. 1c), suggesting that ICP27
plays a major role in HSV-1-induced DoTT. Two speciﬁc
examples of DoTT in cells infected with the various mutant
viruses are shown in Fig. 1d (SRSF3) and Supplementary Fig. 1
(DDX5). In contrast to uninfected cells, transcription continued
over 30 kilobases (kb) downstream of the PAS in both genes.
While DoTT was observed for all mutant viruses including
ΔICP4, TsK and ΔICP27, read-through transcription protruded
substantially less in ΔICP27 infection. These data suggest that
multiple factors contribute to HSV-1-induced DoTT and that
ICP27 plays a major role in this process.
In absence of ICP4, viral gene expression is restricted to the
four remaining immediate early genes (ICP0, ICP22, ICP27,
and ICP47). To directly assess the role of ICP27 in DoTT,
we employed a range of deletion mutants that lack ICP4 in
combination with various other immediate early genes23,24. We
quantiﬁed DoTT for two marker genes (SRSF3 and DDX5) by
qRT-PCR upon infection of primary human ﬁbroblasts with the
respective mutant viruses (Fig. 1e). While deletion of ICP4 only
resulted in a modest (~2-fold) reduction in read-through,
knockout of ICP27 signiﬁcantly reduced read-through transcrip-
tion by > 20-fold. This was particularly prominent when compar-
ing the two mutants d103 (expressing only ICP0 and ICP27) and
d106 (expressing only ICP0), which only differ by the expression
of ICP27. Importantly, DoTT could not be rescued by increasing
the dose of infection of both d106 and d107 from a multiplicity of
infection (MOI) of 5–20, thereby excluding dose effects on the
observed differences. We conclude that ICP27 mediates HSV-1
induced DoTT.
ICP27 is sufﬁcient to induce DoTT. We next asked whether
ectopic expression of ICP27 alone was sufﬁcient to induce DoTT.
To this end, we expressed ICP27 in HeLa cells by transient
transfection and performed 4sU-seq. Interestingly, we observed
signiﬁcant DoTT upon transfection of ICP27 but not control
(empty vector) in many host genes, including KDM4C and
SPTSSA (Fig. 2a), similar to HSV-1-induced DoTT. Genome-
wide analysis conﬁrmed extensive transcriptional activity
downstream of the normal transcript end site (TES) in ICP27-
expressing cells (Fig. 2b), albeit that the 4sU-seq signal density
was signiﬁcantly less compared to that in HSV-1 infected cells
(Fig. 2b). In addition to the extent of DoTT, we also analyzed the
pattern of genes that displayed DoTT induced by HSV-1 or
transient transfection of ICP27. Of note, 65% (701 genes) of genes
with signiﬁcant DoTT (5-fold change in 4sU-seq signal down-
stream/upstream of PAS) in ICP27-expressing cells also displayed
similar defect in HSV-1-infected cells (Fig. 2c). Together, these
results strongly suggest that ICP27 by itself is sufﬁcient for
inhibiting RNAPII transcription termination and is a major
contributor of HSV-1-induced DoTT.
ICP27 interacts speciﬁcally with CPSF. To understand
how ICP27 inhibits RNAPII transcription termination, we ﬁrst
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identiﬁed the host factors that are associated with ICP27 during
HSV-1 infection. We immunoprecipitated ICP27 from WT HSV-
1-infected HeLa cells and identiﬁed the precipitated proteins by
mass spectrometry analysis. Lysates from HeLa cells infected with
an ICP27 null mutant (27LacZ) served as controls. All lysates
were treated with RNase A/T1 prior to Immunoprecipitation (IP)
to facilitate detection of protein–protein interactions. Proteins
that were speciﬁcally identiﬁed in WT- but not in 27lacZ virus-
infected cells were considered as ICP27-associated proteins
(Supplementary Fig. 2a and Supplementary Data 1). Among the
co-precipitated proteins were PABP1 and 11 cellular proteins
with known functions in mRNA export (purple dots in Fig. 3a),
consist with the known function of ICP27 in mRNA export21.
Interestingly, we also identiﬁed four subunits of the CPSF com-
plex (CPSF73, Fip1, CPSF160, and CPSF30) as ICP27-associated
factors (blue dots, Fig. 3a). As mentioned earlier, mRNA 3′
processing is required for RNAPII transcription termination1–4.
Knockdown of CPSF subunits, such as CPSF73, has been shown
to induce DoTT25,26. Thus, we hypothesized that ICP27 inhibits
transcription termination via its interaction with CPSF.
To test this hypothesis, we characterized the interactions
between ICP27 and CPSF. We ﬁrst validated the interactome
mapping results by immunoprecipitating ICP27 following HSV-1
infection and analyzing the precipitated proteins by western
blotting. Consistent with our mass spectrometry results, CPSF
subunits including CPSF160, CPSF100, CPSF73, CPSF30, Wdr33,
and Fip1, all co-precipitated with ICP27 (Fig. 3b). By contrast,
other mRNA 3′ processing factors, including CstF and CFIm
subunits, were not detected at signiﬁcant levels (Fig. 3b),
suggesting that ICP27 speciﬁcally interacts with the CPSF
complex. Symplekin is a core component of the mRNA 3′
processing machinery and it associates with both CPSF and CstF
complex27,28. Intriguingly, little to no symplekin was detected in
ICP27 IP samples (Fig. 3b). We next determined if the
interactions between ICP27 and CPSF required any other viral
factors. To this end, we immunoprecipitated ICP27 upon
transient transfection in 293T cells and performed mass spectro-
metry and western blotting analysis of the IP samples. Consistent
with our IP analyses of HSV-1-infected cells, ectopically
expressed ICP27 co-precipitated CPSF subunits, but not
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Fig. 1 ICP27 is a major contributor for HSV-1-induced disruption of transcription termination. a Boxplots showing the distribution of read-through at
different time points post-infection during HSV-1 wild-type infection (time-course). b Boxplots showing the distribution of read-through in cells infected
with wild-type and various mutant viruses at 7–8 h (WT, Δvhs, ΔICP4, ΔICP27) and 11–12 h (ΔICP22, ΔICP0) post-infection. Please note that read-through
at 7–8 h post-infection shown here is from a repeat experiment performed together with the mutant viruses. Read-through at 0–1 h post-infection from the
WT time-course is also shown. c Median read-through values for each condition and time-point are plotted against the variance in log2 gene expression
(=gene FPKM) fold-changes. The gray curve indicates the result of linear ﬁt on all HSV-1 infection time-points from the time-course experiment. dMapped
4sU-seq reads for SRSF3 in cells infected with wild-type or various mutant HSV-1 strains. The region where transcription termination occurs in mock-
infected cells is shaded. e Primary human ﬁbroblasts infected were infected for 8 h with mutant viruses lacking various immediate early genes. The genes
that are still expressed by the individual mutants as well as the employed multiplicity of infection are indicated in the table below the graph. Read-through
transcription was quantiﬁed by qRT-PCR data and plotted as mean ± s.e.m. (n= 5).
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other mRNA 3′ processing factors (Supplementary Fig. 2b and
Supplementary Data 1). Furthermore, symplekin again did not
co-precipitate with ICP27 (Supplementary Fig. 2b), indicating
that ICP27 and symplekin may bind to CPSF complex in a
mutually exclusively manner. Together these results demonstrate
that ICP27 speciﬁcally interacts with CPSF and that this
interaction does not require other viral proteins.
We next determined which CPSF subunit(s) directly interact
with ICP27. We puriﬁed recombinant GST-ICP27 and various
mRNA 3′ processing factors and performed GST pulldown
assays. Among the tested 3′ processing factors, GST-ICP27 pulled
down Fip1 and CPSF73 of the CPSF complex, but not CstF
(Fig. 3c), indicating that ICP27 directly interacts with multiple
subunits of the CPSF complex. ICP27 contains a number of
known functional domains, including the Leucine-rich region, the
RGG box, and the C-terminal zinc ﬁnger domain (Fig. 3d, top
panel)29. In order to map the domain(s) that mediate CPSF
interaction, we expressed Flag-tagged WT or various mutant
ICP27 by transient transfection, and performed IP with anti-Flag
antibodies. The mutant ICP27 included deletion mutants in
which speciﬁc domain/regions were deleted, such as dLeu, d1-2,
d2-3, d4-5, and d5-6 (Fig. 3d). In addition, m15 is a substitution
of PG to LE at amino acids 465, 466, and m16 is a C to L
substitution at residue 48830. n406 has a stop codon in all three
reading frames at amino acid 406 and n504 has a stop codon in
all three reading frames at amino acid 50431. Interestingly, the
CPSF subunits, Fip1 and CPSF73, were efﬁciently co-precipitated
by ICP27 mutants lacking the N-terminal region, the NLS, and
the RGG box. However, little or no Fip1 or CPSF73 were
co-precipitated by ICP27 mutants in which the C-terminal
regions were deleted or mutated (m15, m16, n406, and n504,
Fig. 3d). We conclude that the C-terminal domain of ICP27 is
necessary for mediating interactions with CPSF.
ICP27 represses mRNA 3′ end processing. To test whether
ICP27 affects mRNA 3′ processing, we performed in vitro 3′
processing assays. We incubated recombinant ICP27 with nuclear
extract (NE) from HeLa cells and assessed mRNA 3′ cleavage of
L3, a commonly used PAS RNA derived from adenovirus major
late transcript. MBP-MS2, another RNA-binding protein, served
as a control. Interestingly, ICP27 inhibited mRNA 3′ cleavage of
L3 in a dose-dependent manner while MBP-MS2 had no effect
(Fig. 4a). We also tested several other human and viral PASs
using the same assay and found that ICP27 inhibited the cleavage
of all tested PASs including the PAS of the ICP27 gene itself
(Fig. 4a, lower panel, and Supplementary Fig. 3a). These data
demonstrate that ICP27 inhibits mRNA 3′ processing in vitro.
To test the impact of ICP27 on mRNA 3′ processing in living
cells, we took advantage of a dual luciferase reporter pPASPORT
(Fig. 4b)32. In this reporter, Renilla (Rluc) and Fireﬂy luciferase
(Fluc) genes are expressed from a bicistronic mRNA in which
translation of the downstream Fluc gene is driven by an internal
ribosomal entry site (IRES). A candidate PAS to be tested is
inserted between the two luciferase genes. If cleavage/polyadeny-
lation occurs efﬁciently at the candidate PAS, only Rluc is
expressed. In contrast, inefﬁcient 3′ processing will lead to
transcription read-through and termination at the strong
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downstream β-globin PAS, thereby resulting in the expression
of both Rluc and Fluc. The Rluc/Fluc ratio thus provides a
quantitative measurement of RNA cleavage/polyadenylation
efﬁciency at the candidate PAS32–34.
Consistent with our in vitro data, expression of
ICP27 signiﬁcantly suppressed mRNA 3′ processing of all seven
different PASs (three human, four viral) we tested (Fig. 4b).
As ICP27 is known to regulate mRNA export and translation22,35,
we wanted to determine if the effect of ICP27 observed in our
reporter assay was due to its direct role in regulating mRNA 3′
processing. To this end, we isolated RNAs from the reporter
assays and performed 3′ Rapid Ampliﬁcation of cDNA Ends
(RACE) (Supplementary Fig. 3b). In this assay, the two RNA
isoforms expressed from the pPASPORT construct were
ampliﬁed into two distinct PCR products in the same reaction.
In the absence of ICP27, both RNA isoforms were detected
(Supplementary Fig. 3b, lanes 1, 3, and 5). Co-expression of
ICP27, however, led to a signiﬁcant decrease in the shorter RNA
isoform containing only Rluc (Supplementary Fig. 3b, lanes 2, 4,
and 6), suggesting that ICP27 inhibited mRNA 3′ processing at
the upstream PAS. These results demonstrate that the inhibitory
effect of ICP27 observed in our reporter assay (Fig. 4b) was due to
a direct role in regulating mRNA 3′ processing and not caused by
other indirect effects. We conclude that ICP27 broadly inhibits
mRNA 3′ processing. It is important to note that not only cellular
but also the two HSV-1 viral PASs (of ICP27 and ICP22) that we
tested were inhibited by ICP27, suggesting that the core PAS
(from −100 nucleotides (nt) to +100 nt relative to the cleavage
site) alone is not sufﬁcient for ICP27 to distinguish between viral
and host PASs.
We next mapped the domain/regions of ICP27 that are
necessary for inhibiting mRNA 3′ processing. We over-expressed
the WT or various mutant ICP27 and checked their effect on
mRNA 3′ processing using the reporter assay. Our results
demonstrate that mutant ICP27 with N-terminal deletions, such
as dLeu and d1-2, inhibited mRNA 3′ processing to a similar
degree as the WT ICP27 while the C-terminal mutants (m15 and
n504) lost this ability (Fig. 4c). Additionally, we also compared
the activities of the WT and mutant ICP27 in inhibiting host gene
transcription termination by qRT-PCR. Consistent with the
reporter assay results, the N-terminal deletion mutants of
ICP27 strongly induced DoTT of host genes, similar to the WT
ICP27. By contrast, the C-terminal mutants had no signiﬁcant
effect (Fig. 4d). Together these data suggest that the C-terminal
domain of ICP27 is required for its interactions with CPSF and its
inhibition of mRNA 3′ processing and transcription termination.
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ICP27 interferes with mRNA 3′ processing complex assembly.
To assess which step of mRNA 3′ processing ICP27 interferes
with, we ﬁrst monitored the assembly of the mRNA 3′ processing
complex, the earliest step of mRNA 3′ processing11. L3 or ICP27
PAS-containing RNAs were incubated with NE under cleavage/
polyadenylation conditions and then resolved by native PAGE. In
the absence of ICP27 (Fig. 4e, lanes 1 and 5), the mRNA 3′
processing complex (P complex) efﬁciently assembled on both
RNA substrates. In the presence of ICP27, however, the P com-
plex migrated faster on the gel and appeared more diffused
(Fig. 4e, compare lanes 2–3 to lane 1 and compare lanes 6–7 to
lane 5) although complex formation (overall signals) seemed
unaffected. The control protein, MBP-MS2, had no effect. This
suggests that ICP27 induces the assembly of an aberrant mRNA
3′ processing complex that may be compositionally and/or con-
formationally distinct from the normal complex.
To directly compare the composition of the mRNA 3′
processing complexes assembled in the presence or absence of
ICP27, we puriﬁed these complexes using an RNA afﬁnity
approach28,36. Brieﬂy, PAS-containing RNAs were fused to three
tandem copies of the MS2 hairpin (the MS2 hairpins are ~60 nt
upstream of the cleavage site). These RNA substrates were ﬁrst
incubated with MBP-MS2, which binds to the MS2 hairpins, and
then with NE to allow for the assembly of mRNA 3′ processing
complexes. These complexes were then pulled down by using
amylose beads and analyzed by western blotting. By comparing
the mRNA 3′ processing complexes assembled on L3 and ICP27
PAS with or without recombinant ICP27 protein (Fig. 4f), we
conﬁrmed that ICP27 associates with the mRNA 3′ processing
complex (Fig. 4f, lanes 4 and 8). Furthermore, nearly all mRNA 3′
processing factors assembled at similar levels in the mRNA 3′
processing complex in the presence or absence of ICP27 (Fig. 4f,
compare lanes 3 and 4 or 7 and 8). However, symplekin and
CstF64 seemed to display a modest decrease (Fig. 4f, compare
lanes 3 and 4 or 7 and 8). Together with our earlier observation
that the ICP27-associated CPSF complex lacks symplekin
(Fig. 3b), these results indicate that ICP27 interaction with CPSF
prevents its stable association with symplekin and CstF.
Furthermore, when we resolved the afﬁnity puriﬁed P complexes
assembled in the absence or presence of ICP27 by glycerol
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gradient sedimentation, we observed that the P complexes
assembled in the presence of ICP27 failed to reach higher density
fractions and spread out into more gradient fractions (Supple-
mentary Fig. 4). This is consistent with our previous observation
that the P complex assembled in the presence of ICP27 not only
migrated faster but also appeared more diffuse on native gels
(Fig. 4e). We conclude that ICP27 does not block the assembly of
mRNA 3′ processing complex but rather interferes with mRNA 3′
processing by preventing the assembly of a functional mRNA 3′
processing complex.
ICP27 activates viral mRNA 3′ processing. HSV-1 induces
DoTT in thousands of host genes, while transcription termination
for HSV-1 as well as some host genes remains mostly unaf-
fected13. However, ICP27 inhibits mRNA 3′ processing of all
PASs that we tested, including viral PASs (Fig. 4 and Supple-
mentary Fig. 3). To understand the molecular basis for the spe-
ciﬁcity of HSV-1-induced DoTT, we selected four PAS for further
studies. These included two cellular PASs displaying strong HSV-
1 induced DoTT (SPTSSA and KDM4C, see Fig. 2a). In addition,
we included a host PAS (POLR2A) and a viral PAS (ICP27), both
of which showed normal transcription termination in HSV-1-
infected cells (Supplementary Fig. 5). When we tested the core
sequences of these PASs (from −100 nt to +100 nt relative to the
cleavage site) in the pPASPORT assays, we again observed strong
inhibition of mRNA 3′ processing by ICP27 (Fig. 5a). As the core
PAS sequences were apparently not sufﬁcient to explain the
speciﬁcity of ICP27-induced transcription termination, we asked
if sequences upstream of the PAS (UPS) could determine
such speciﬁcity. We thus cloned the four aforementioned
PASs with 1440 nt UPS from the endogenous genes and
tested these extended PASs using the pPASPORT assays. Again,
ICP27 strongly inhibited mRNA 3′ processing at the extended
SPTSSA and KDM4C PAS (Fig. 5b). By contrast, ICP27 now
failed to inhibit mRNA 3′ processing at the extended POLR2A
PAS. Strikingly, ICP27 even activated mRNA 3′ processing at the
extended ICP27 PAS by over 2-fold (Fig. 5b). We performed 3′
RACE to conﬁrm that, although ICP27 inhibited the usage of the
core ICP27 PAS, it stimulated its usage when UPS was included
(Supplementary Fig. 6). These data suggest that the UPS plays an
important role in determining how ICP27 inﬂuences mRNA 3′
processing.
Next, we tested if the UPSs alone are sufﬁcient to determine the
mode of ICP27 action. To this end, we generated chimeric PAS
between KDM4C and ICP27, in which the UPSs and the PAS
were exchanged (Fig. 5c). Although ICP27 inhibited 3′ processing
at the core and extended KDM4C PASs (Fig. 5a–b), it had no
signiﬁcant effect when the KDM4C PAS was fused to ICP27 UPS
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(Fig. 5c). Conversely, ICP27 inhibited mRNA 3′ processing at the
core ICP27 PAS but functioned as an activator for the extended
ICP27 PAS (Fig. 5a–b). When the KDM4C UPS was fused to the
ICP27 core PAS, this chimeric PAS was strongly inhibited by
ICP27 (Fig. 5c), similar to the extended KDM4C PAS itself.
Therefore, UPS plays a critical role in determining the bimodal
activities of ICP27.
ICP27-RNA interactions modulate its effect on 3′ processing.
How do UPSs determine ICP27 activities? It has been proposed
that ICP27 binds to GC-rich sequences in the viral mRNAs37. The
GC content of the ICP27 UPS was substantially higher than that of
the KDM4C UPS (70.5% vs. 44.1%) (Fig. 5c). This is a general
feature of viral vs. cellular UPS (68.3% vs. 40.1%) (Fig. 5d).
Additionally, we compared the sequences of host genes that dis-
played signiﬁcant DoTT in HSV-1-infected cells to those without
signiﬁcant defects. PAS and surrounding sequences of host genes
without DoTT had signiﬁcantly higher GC content than those
with termination defect (Fig. 5e, p value= 8.8e−38 by K-S test).
These data provide evidence that there is an anti-correlation
between the GC-content of PAS and their susceptibility to ICP27-
mediated inhibition. We thus hypothesized that ICP27 does not
inhibit mRNA 3′ processing when bound near a PAS.
To test this hypothesis, we mapped the global ICP27-RNA
interaction landscape by CLIP-seq (UV crosslinking and immu-
noprecipitation followed by high throughput sequencing)38. We
performed this analysis both in HSV-1-infected and ICP27-
overexpressing (O/E) cells (Supplementary Fig. 7). We found that
ICP27 preferentially binds cellular mRNAs close to PAS or TESs
and, to a lesser degree, at transcription start sites (TSS) (Fig. 6a).
Motif analysis of ICP27 RNA binding sites revealed an enrichment
of GC-rich sequences (Fig. 6b), consistent with previous in vitro
studies37. Additionally, AATAAA was enriched in ICP27-
associated sequences, consistent with the observed strong
ICP27–RNA interactions near PAS/TES (Fig. 6a). These results
suggest that ICP27 preferentially binds to GC-rich UPS of PAS.
We next determined whether ICP27 differentially binds to PAS
of host genes with or without HSV-1-induced DoTT. While low
levels of ICP27–RNA interactions were detected near the PAS of
genes with DoTT (Fig. 6c, red line), ICP27 CLIP-seq signals were
detected more frequently at PAS without DoTT (Fig. 6c, green
line). As exempliﬁed by the SRSF3 gene that displayed strong
DoTT in HSV-1-infected cells (Fig. 1d, 6e), no signiﬁcant ICP27
CLIP signal was detected near the SRSF3 PAS (Fig. 6e, left panel).
The fact that ICP27 CLIP signals were observed in the 5′ quarter
of the mRNA excludes low expression levels or low sensitivity to
be responsible for the lack of signal near PAS. By contrast,
GAPDH showed little or no DoTT in HSV-1-infected cells, but
strong and selective ICP27–RNA interactions were detected
upstream of its PAS (Fig. 6e, right panel). Together our 4sU-seq
and CLIP-seq analyses demonstrate that ICP27 preferentially
binds to PASs in genes without DoTT (Fig. 6c).
Since HSV-1 speciﬁcally blocks transcription termination of
host genes without affecting viral genes, we compared the
ICP27–RNA interactions at host and viral PASs. As shown in
Fig. 6d, the overall ICP27 CLIP signals (from −1 kb to +1 kb
relative to the cleavage site, normalized by RNA levels) were
signiﬁcantly higher at viral PASs than at host PASs, suggesting
that ICP27 predominantly binds to viral transcripts. This is
consistent with the higher GC-content of the viral genome
(Fig. 5d). The anti-correlation between ICP27–RNA interaction
and HSV-1-induced DoTT suggests that, once bound to the UPS
of a PAS, ICP27 does not induce DoTT.
We directly tested this concept in the following three
experiments. First, we synthesized a 100-nt RNA fragment from
the UPS of ICP27 (GC content: 63%), which showed no DoTT in
HSV-1-infected cells, and another fragment from KDM4C (GC
content: 41%), which displayed strong DoTT following HSV-1
infection (Fig. 2a). In vitro gel mobility shift assays demonstrated
that recombinant ICP27 strongly binds to the GC-rich ICP27
RNA fragment while much weaker binding was observed for the
KDM4C fragment (Supplementary Fig. 8a). Next we inserted one
or two tandem copies of these RNA fragments upstream of a
human PAS that is inhibited by ICP27 and tested how these
fragments modulate the inhibitory effect of ICP27 using
pPASPORT assay (Supplementary Fig. 8b). The ICP27 UPS
RNA fragment alleviated ICP27-mediated inhibition of mRNA 3′
processing while the KDM4C UPS fragment had no effect
(Supplementary Fig. 8b), suggesting that ICP27 interactions with
RNA sequences upstream of PASs alleviate ICP27-mediated
inhibition of mRNA 3′ processing.
Secondly, we tested if the RNA-binding domain of ICP27, the
RGG box, is necessary for its activation function. We repeated
the reporter assay as described in Fig. 5c with either the WT
ICP27 or the d4-5 mutant, which lacks the RGG box. Consistent
with our earlier results, ICP27 activated the extended ICP27
PAS and had little effect on the KDM4C fused to the ICP27 UPS
(Fig. 6f). Interestingly, however, the d4-5 mutant failed to
activate the extended ICP27 PAS and even inhibited both PAS
(Fig. 6f), strongly suggesting that the activation function of
ICP27 requires its RGG domain and therefore its RNA-binding
activity.
Finally, we tested our model using a tethering assay. We
inserted two copies of the BoxB hairpin upstream of a host gene
(BASP1) or ICP27 core PAS (172 nt and 121 nt upstream of the
cleavage site, respectively) in pPASPORT (Supplementary Fig. 8c).
We then co-expressed these reporters with an empty vector, Flag-
ICP27, or λN-Flag-ICP27-expressing plasmids. The expression of
Flag-ICP27 signiﬁcantly repressed mRNA 3′ processing at both
PASs (Fig. 6g), consistent with our earlier results (Fig. 4b, 5a). By
contrast, the expression of λN-Flag-ICP27, which was tethered to
the BoxB-containing PAS through its interactions with the BoxB
sequences39, had no inhibitory effect (Fig. 6g), suggesting that
interactions with RNA prevent ICP27 from inhibiting mRNA 3′
processing. Taken together, we conclude that ICP27 is a general
inhibitor of mRNA 3′ processing by disrupting the assembly of a
functional mRNA 3′ processing complex. However, by interacting
with GC-rich RNA sequences upstream of the PAS, it can activate
mRNA 3′ processing, most likely by recruiting the CPSF complex
to its target mRNAs.
Discussion
Recent studies revealed that transcription termination is regulated
by viral infections and cellular stresses13–15,40, and that increased
DoTT is associated with cancer16. To understand the underlying
mechanisms, we carried out an in-depth study of HSV-1-induced
DoTT. We found that the HSV-1 immediate early protein ICP27
is sufﬁcient for inducing DoTT when ectopically expressed in
human cells. Mechanistically, ICP27 causes DoTT by inducing
the assembly of an aberrant mRNA 3′ processing complex via its
interactions with the CPSF complex and blocking/delaying
mRNA 3′ cleavage. Importantly, ICP27 can also function as a
sequence-dependent activator of 3′ end processing, thereby
explaining efﬁcient transcription termination of viral transcripts
(Fig. 7). It does so through binding to GC-rich sequences
upstream of PAS and most likely promoting recruitment of CPSF
and other mRNA 3′ processing factors. As transcription termi-
nation signiﬁcantly impacts mRNA production and the sub-
sequent translation13, the bimodal activity of ICP27 plays a major
role in HSV-1-mediated host shutoff.
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mRNA 3′ processing factors are also targeted by other viruses.
For example, inﬂuenza virus infection or ectopic expression of the
inﬂuenza viral protein NS1 causes transcription termination
defects of host genes40,41. NS1 inhibits host mRNA 3′ processing
by speciﬁcally binding to the CPSF subunit CPSF30 (ref. 42).
CPSF contains an RNA-binding module (CPSF30, Wdr33,
CPSF160, and Fip1) and a cleavage module (CPSF73, CPSF100,
and symplekin)43–45. As CPSF30 directly binds to the poly(A)
signal, AAUAAA, NS1–CPSF30 interaction blocks PAS
recognition43,44,46,47. Here, we showed that the HSV-1 protein
ICP27 directly binds to both modules of CPSF. In contrast to the
inﬂuenza virus mechanism, however, ICP27 does not block
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CPSF–RNA interaction and, instead, induces the formation of a
“dead-end” 3′ processing complex to block RNA cleavage.
In addition to viruses, cellular stress can also modulate the
activities of mRNA 3′ processing factors. For example, PAP has
been shown to undergo poly(ADP-ribosyl)ation (PARylation)
upon heat shock and this post-translational modiﬁcation inhibits
polyadenylation48. However, as PAP is not required for tran-
scription termination12, PAP poly(ADP-ribosyl)ation is unlikely
to mediate heat shock-induced DoTT/DoGs.
Currently the mechanism for stress-induced DoTT/DoGs is
unknown. Given the signiﬁcant overlaps in the genes displaying
DoTT/DoGs upon viral infection and cellular stress15, we
speculate that the mechanism described in this report may have
broad implications for understanding stress-induced DoTT/
DoG. For example, we showed that ICP27 binds to CPSF and
partially displaces symplekin (Figs. 3–4). Interestingly, previous
studies have characterized symplekin as a heat labile factor49.
Therefore, it is possible that heat shock and other cellular stress
may lead to degradation or inactivation of symplekin, which in
turn results in a failure in mRNA 3′ processing and transcrip-
tion termination. Additionally, the heat shock transcription
factor 1 (HSF1) binds to symplekin upon heat shock and this
interaction may promote the mRNA 3′ processing of heat shock
protein genes50. Therefore, symplekin as well as other mRNA 3′
processing factors may be involved in both the general inhibi-
tion and speciﬁc activation of transcription termination in cells
infected with virus or under stress.
Finally, it should be pointed out that herpesviruses vary in their
impact on transcription termination and their ICP27 homologs.
First, both murine and human cytomegalovirus do not induce
DoTT based on published RNA-seq datasets51,52. Second, HSV-1
and HSV-2 are the only human herpesviruses with a high GC
content (~70%). The other human herpesviruses, VZV, HCMV,
EBV, and KSHV, do not have a high GC content (<60%). Third,
although ICP27 is conserved among herpes viruses, ICP27
homologs in HCMV (UL69), EBV (SM protein), and KSHV
(ORF57) do not have the same RNA-binding domain (RGG box)
and their RNA binding speciﬁcities have not been fully
deﬁned53,54. Taken together, these results suggest that herpes-
viruses are quite divergent and further studies are needed to fully
elucidate their interactions with RNAs and host factors as well as
in their impact on transcription termination.
Methods
Cell culture, viruses, and infection. Human foreskin ﬁbroblasts (HFF, #86031405,
purchased from ECACC) were cultured in DMEM, high glucose, pyruvate
(Thermo Fisher #41966052) supplemented with 1× MEM non-essential amino
acids (Thermo Fisher #11140050), 1 mM additional sodium pyruvate (Thermo
Fisher #11360070), 10% (v/v) fetal bovine serum (FBS, Biochrom #S0115), 200 IU/
ml, penicillin (pen), and 200 µg/ml streptomycin (strep). HEK293 and HeLa cell
lines were cultured in Dulbecco’s modiﬁed Eagle medium (DMEM) with 10% FBS.
All cells were incubated at 37 °C in a 5% (v/v) CO2-enriched incubator. Virus
stocks for WT HSV-1 strain 17 as well as the null mutants of vhs55, ICP0 (FXE,
strain 17)56, ICP22 (R325, strain F)57, and TsK (strain 17)58 were produced on
baby hamster kidney (BHK) cells as described13. The temperature-sensitive mutant
Tsk was grown at 31 °C. Infections were subsequently performed at 39 °C to render
ICP4 inactive. Stocks of the ICP27 null mutant were produced on complementing
Vero 2-2 cells59. Null mutants of multiple immediate early genes (d100, d103,
d106, d107) were a kind gift of Neal DeLuca, grown on complementing cells lines
and titrated as described23,24. Cells were infected with an MOI of 10 unless
otherwise speciﬁed and incubated at 37 °C until cells were harvested at the speciﬁed
time points.
qRT-PCR. Total RNA was isolated using Trizol reagent following the manu-
facturer’s instructions. Reverse transcription was performed using All-in-One
cDNA Synthesis Supermix (Biotool) including a mix of hexanucleotide random
primers and poly-dT primers. qRT-PCR was performed using the SYBR Green 2x
Mastermix (Biotool) (qRT-PCR primer sequences in Supplementary Data 2).
Relative quantitation was performed using the ΔΔCT approach comparing relative
transcript levels downstream and upstream of the PAS.
3′ RACE. Total RNA was isolated using Trizol from pPASPORT-transfected cells
and 1 μg of total RNA was used to perform reverse transcription using 3′RACE-RT
primer and M-MLV (Promega) in 20 μl reaction. cDNA was diluted by ﬁve times
and 1 μl was used to do ﬁrst round PCR with 3′RACE-R1, Renilla-F1, and Fireﬂy-
F1 primers in one reaction. A total of 1 μl of PCR product from ﬁrst round PCR
was used to carry out the second round PCR with primers 3′RACE-R2, Renilla-F2,
and Fireﬂy-F2. PCR products were resolved on 2% agarose gels.
Reporter assay. PAS sequences were cloned into the multiple cloning sites in
pPASPORT. A total of 0.1 μg of reporter constructs were co-transfected with 0.1 μg
of ICP27-expressing plasmid into HeLa cells using Polyethylenimine (PEI). Cells
were harvested 36 h.p.i. and the Fluc/Rluc ratio was determined using the Dual
Luciferase Assay Kit (Promega). For λN Tethering assay, empty vector or ICP27-
expressing plasmids and 2× BoxB-BASP1-pPASPORT were co-transfected and the
luciferase activities were measured by using the same method. All reporters assays
were carried out with three replicates.
In vitro cleavage assay. All PASs were cloned into pBluescript II KS+ vector, and
the RNA substrates were synthesized by in vitro transcription with T7 polymerase
in the presence of [α-32P]-UTP. In vitro assays for coupled cleavage/poly-
adenylation assay were performed with HeLa NE as previously described28.
Protein puriﬁcation. The ICP27 cDNA was cloned in pGEX-4T-1 for GST-ICP27
and pET-51b(+) for Strep-ICP27. MBP-ICP27, GST-ICP27, and Strep-ICP27
fusion proteins were expressed in Escherichia coli and puriﬁed using amylose beads
(NEB), glutathione sepharose (GE Healthcare), and Strep-Tactin® Sepharose
(IBA Lifesciences), respectively. Fip1, CPSF73, and CstF cDNAs were cloned into
pFastBac. The pFastBac and MultiBac constructs were used to produce recombi-
nant baculoviruses using standard procedures. Baculoviruses were used to infect
Sf9 cells and cells were harvested 2 days post-infection. Recombinant proteins were
puriﬁed with Cobalt beads per manufacturer’s instructions (Fisher).
4sU-seq. 4sU was added to 5 ml of medium at 500 μM for each 10 cm dish and
incubated for 1 h before cells were harvested. For HSV1-infected cells, 4sU was
added at 7 h post infection. One hour later, medium was discarded and cells were
lysed using 3 ml of Trizol (Invitrogen). Total RNAs were isolated from the cells
following the manufacturer’s instructions. A total of 700 μl of thiol-speciﬁc bioti-
nylation reaction contained 70 μg of total RNA, 70 μl of 10× Biotinylation Buffer
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Fig. 7 A model for ICP27-mediated regulation of mRNA 3′ processing. In
HSV-1-infected cells, ICP27 interacts with CPSF and induces the assembly
of an aberrant 3′ processing complex. At viral PASs or host PASs that have
GC-rich upstream sequences (UPS), ICP27 binds to these UPS sequences
and promotes recruitment of CPSF, thereby activating mRNA 3′ processing.
The transition of ICP27 between the CPSF-bound and UPS RNA-bound
states is illustrated by a dotted line.
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(100 mM Tris-Cl pH 7.5 and 10 mM EDTA), 140 μl of biotin-HPDP (in 1 mg/ml
DMF), and 70 μl of DMF. This was incubated at room temperature for 1.5 h with
rotation. Excessive Biotin-HPDP was removed by chloroform extraction twice.
RNA was precipitated, washed once with 75% ethanol, and re-suspended in 100 μl
of H2O. Biotinylated RNA samples were heated to 65 °C for 10 min and imme-
diately placed on ice. A total of 100 μl of pre-washed streptavidin-magnetic beads
were washed with 800 μl of 1× washing buffer (5 mM Tris-Cl pH 7.5, 0.5 mM
EDTA, and 1M NaCl) for 3 × 5 min and incubated with 100 μl of 0.1 M DTT for
2 × 5 min at room temperature; 1/10 the volume of 5M NaCl and an equal volume
of isopropanol and 1 μl of glycoblue were added to precipitate RNA.
CLIP-seq. We used a modiﬁed version of eCLIP. Brieﬂy, infected and transfected
HeLa cells were exposed to 254 nM UV with 400 mJ/cm2, and then scrapped and
re-suspended in lysis buffer (50 mM Tris-HCl pH 7.4, 100 mM NaCl, 1% NP-40,
0.1% SDS, 0.5% sodium deoxycholate, and protease inhibitor). After RNase I
digestion, 80 μl of protein G Dynabeads beads and 5 μg of ICP27 antibody per IP
were used for immunoprecipitation overnight. After washing with high salt buffer
(50 mM Tris-HCl pH 7.4, 1 M NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS, and 0.5%
sodium deoxycholate) and wash buffer (20 mM Tris-HCl pH 7.4, 10 mM MgCl2,
and 0.2% Tween-20), phosphates at 5′ and 3′ end of RNA were removed by CIP
(NEB) for 15 min at 37 °C. 3′ RNA linker was added by T4 RNA ligase (Thermo
Fisher Scientiﬁc) overnight and [γ-32P]ATP (PerkinElmer) was used to label the
5′ end of RNA by T4 PNK (NEB). ICP27/RNA complex was resolved in 4–12%
NuPAGE (Invitrogen) and transferred to NC membrane. Proper regions of
membrane were cut out to extract RNA in PK/Urea buffer. Extracted RNA was
added with 5′ RNA linker by T4 RNA ligase and reverse-transcribed with Super-
script III (Invitrogen). Libraries for CLIP-seq were generated by PCR using Illu-
mina universal primer and index primers.
Immunoprecipitation and western blotting. Cells in 10 cm dishes were harvested
by trypsinization and washed once with PBS. Cells were then re-suspended in 1 ml
of IP buffer (150 mM NaCl, 10 mM Tris-HCl pH 7.4, 1 mM EDTA pH 8.0, 1%
Triton X-100, and 0.5% NP-40) containing 1× protease inhibitor and 10 μg of
RNase A/T1, and rotated for 10 min at 4 °C followed by sonication. Cell lysates
were cleared by centrifugation for 20 min at 4 °C and the supernatant was trans-
ferred to a new 1.7-ml tube. Three micrograms of ICP27 P1119 antibody and 30 μl
of protein G magnetic beads (30 μl of anti-FLAG M2 afﬁnity gel for FLAG-ICP27-
transfected cells) were added in cell lysate and incubated for 4 h at 4 °C. Wash the
beads with 4 × 1ml of IP buffer × 10 min, and then 50 μl of 1× SDS loading buffer
was added to the beads and heated for 5 min at 95 °C. Samples were analyzed by
SDS-PAGE and western blotting. The antibodies for western blotting are as follows:
ICP27 (Virusys, P1113 and P1119), CPSF160 (Bethyl, A301-580A), CPSF100
(Bethyl, A301-581A), CPSF73 (Bethyl, A301-091A), CPSF30 (Bethyl, A301-585A),
Fip1 (Bethyl, A301-462A), Symplekin (Bethyl, A301-465A), WDR33 (Bethyl,
A301-152A), CstF64 (Bethyl, A301-092A), CstF77 (Bethyl, A301-096A), CstF50
(Bethyl, A301-250A), CFIm68 (Bethyl, A201-358A), CFIm59 (Bethyl, A301-360A).
The dilutions for all antibodies are 1:2000.
Gel shift assay. [α-32P]-UTP-labeled RNA was incubated with 1 mM ATP, 20mM
creatine phosphate, 100 ng/μl yeast tRNA, and 44% HeLa NE in 10 μl reaction at 30
°C for 20min. The reactions were cooled on ice and heparin was added to 0.4 μg/μl;
6 μl of the reaction was resolved on 4% native PAGE in 1× Tris-Glycine running
buffer at 100 V for 210min in cold room and visualized by phosphor imaging.
Glycerol gradient sedimentation and RNA pulldown. A total of 10 pmol of
3MS2-ICP27pA RNA was incubated with 500 pmol of MBP-MS2 fusion protein on
ice for 30 min, and then mixed with 1 mM ATP, 20 mM creatine phosphate,
100 ng/μl yeast tRNA, and 200 μl of HeLa NE in 500-μl reaction with/without 25 μg
of GST-ICP27. The reaction mix was incubated at 30 °C for 20 min followed by
chilling on ice. Heparin was added to 0.4 μg/μl. The whole reaction was performed
on 10–30% glycerol gradient sedimentation at 30k rpm for 15 h, and fractions were
collected manually from top at 0.5 ml/fraction; 20 μl of pre-washed amylose beads
were mixed with each fraction and rotated for 1 h at 4 °C. Beads were washed with
wash buffer (20 mM HEPES-KOH (pH 7.9), 100 mM KCl, 1 mM MgCl2, 1% Triton
X-100, and 0.5 mM DTT) for 3 × 10 min and then the complexes were eluted with
120 μl of wash buffer plus 12 mM maltose for 2 × 20 min at 4 °C. Eluted proteins
were precipitated with acetone overnight at −20 °C and analyzed by SDS-PAGE
followed by silver staining or western blotting.
Data analysis. 4sU-seq data in Fig. 1 and Supplementary Fig. S1 were mapped
against hg19, human rRNA sequences, and HSV-1 strain 17 using ContextMap
v2.7.9. Other sequencing data were mapped to human genome (hg19) and/or HSV
KOS using STAR version 2.5.2a (ref. 60). No multimapping was allowed in align-
ment. Bigwig ﬁles were then generated using deepTools v3.0.2 with RPKM
normalization.
CLIP data were pre-processed by Cutadapt, and the adapter sequence or any
tails of “A”s were trimmed prior to the alignment. For these data, peaks were called
using GEM61 with the suggested setting for CLIP data. Peak calling was done for
each strand separately and then the results were merged.
Read distribution data around termination sites or gene body were
generated using deepTools. Peak distribution data were extracted by Homer
software62. The visualization and any post-processing step then were done in
Python.
Termination defect was studied based on the ratio of reads mapped on 5 kb
downstream of the termination site to the expression of the gene. This ratio
(termination ratio) was calculated for each gene and in all conditions, and its
change was used as the measure of termination defect. Bedtools63 was used to
extract the downstream region, and featureCounts64 generated the read counts.
The read counts were normalized by the length of the genes. Genes were then
ranked based on the change in termination ratio and then based on their coverage
and defected and not defected ones were chosen from this list. We applied a
threshold of 5-fold change for the termination ratio and 5 reads per kilo basepairs
for coverage to ﬁnd the signiﬁcant changes in termination. Genes with a small
change in their termination ratio (<1.1 fold) were marked as the ones with no
signiﬁcant change.
Bedtools was used to extract the sequence for each region under study when
necessary. Any post processing then was done in Python. Motif analysis was done
using DREME65.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
4sU-seq and CLIP-seq data have been deposited to the GEO database (accession number:
GSE128753). The mass spectrometry proteomics data were deposited to the
ProteomeXchange Consortium via the PRIDE partner repository with the dataset
identiﬁer PXD012837. The Source Data for Figs. 3b–d, 4a, e, f, and Supplementary
Figs. 2a, b, 3a, b, 4a, b, and 6–8 are provided as a Source Data ﬁle.
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